John Brancaccio

Insider Reports History

Location
Monmouth Junction, NJ
Signature
/s/ John Brancaccio
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Brancaccio:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cardiff Oncology, Inc. Former Director Stock Options 125,317 $325,824 $2.60 09 Jun 2022 Direct
OKYO Pharma Ltd Director Ordinary Shares 16,670 $25,005 $1.50 15 Sep 2023 Direct
Hepion Pharmaceuticals, Inc. Chairman, Director Stock Options 99,563 19 Feb 2024 Direct

Insider Reports Filed by John Brancaccio

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HEPA Hepion Pharmaceuticals, Inc. 19 Feb 2024 1 $0 4 Chairman, Director 21 Feb 2024, 20:01
OKYO OKYO Pharma Ltd 15 Sep 2023 1 +$25,005 4 Director 28 Sep 2023, 07:15
CRDF Cardiff Oncology, Inc. 09 Jun 2022 9 $0 4 Former Director 09 Jun 2022, 19:48
OKYO OKYO Pharma Ltd 16 May 2022 0 $0 3 Director 16 May 2022, 17:47
CRDF Cardiff Oncology, Inc. 09 Mar 2022 1 $0 4 Director 10 Mar 2022, 17:38
ACUT Accustem Sciences Inc. 01 Dec 2021 0 $0 3 Director 03 Dec 2021, 15:15
CRDF Cardiff Oncology, Inc. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 16:11
HEPA Hepion Pharmaceuticals, Inc. 18 May 2021 1 $0 4 Director 20 May 2021, 16:34